| 【Company Research】Botanee Biotech (300957 CH) – 2Q in line; new brands in anti-aging and baby care to sustain growth |
| 【Fixed Income Research】Yanlord: Ability to navigate through deep downturn demonstrated once again |
| 【Company Research】Pinduoduo (PDD US) – Stronger recovery ahead |
| 【Company Research】PICC P&C (2328 HK) – Strong beat in 1H22 |
| 【Company Research】CPIC (2601 HK) – VNB growth turned positive in June |
| 【Company Research】UEG (467 HK) – On track volume growth along with good cost control |
| 【Company Research】Meituan (3690 HK) – More bullish on 2H22E recovery and profitability |
| 【Company Research】Tigermed (300347 CH) – Solid growth amid COVID-19 outbreaks |
| 【Company Research】Recbio Technology (2179 HK) – Smooth progress of core pipeline products |
| 【Company Research】Wingtech (600745 CH) – 2Q results in line; Maintain BUY |